» Authors » Anna Supernat

Anna Supernat

Explore the profile of Anna Supernat including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 959
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jopek M, Jopek M, Sieczczynski M, Pastuszak K, Lapinska-Szumczyk S, Jassem J, et al.
Blood Adv . 2024 Dec; 9(5):979-989. PMID: 39715465
Ovarian cancer (OC) presents a diagnostic challenge, often resulting in poor patient outcomes. Platelet RNA sequencing, which reflects host response to disease, shows promise for earlier OC detection. This study...
2.
Wenta R, Richert J, Muchlinska A, Senkus E, Suchodolska G, Lapinska-Szumczyk S, et al.
Cytometry A . 2024 Nov; 105(12):883-892. PMID: 39498617
Liquid biopsies developed into a range of sensitive technologies aiming to analyze for example, circulating tumor cells (CTCs) in peripheral blood, which significantly deepens understanding of the metastatic process. Nevertheless,...
3.
Jopek M, Pastuszak K, Sieczczynski M, Cygert S, Zaczek A, Rondina M, et al.
Mol Oncol . 2024 Jun; 18(11):2743-2754. PMID: 38887841
Liquid biopsy demonstrates excellent potential in patient management by providing a minimally invasive and cost-effective approach to detecting and monitoring cancer, even at its early stages. Due to the complexity...
4.
Pastuszak K, Sieczczynski M, Dziegielewska M, Wolniak R, Drewnowska A, Korpal M, et al.
Sci Rep . 2024 May; 14(1):11057. PMID: 38744942
Circulating tumor cells (CTCs) are tumor cells that separate from the solid tumor and enter the bloodstream, which can cause metastasis. Detection and enumeration of CTCs show promising potential as...
5.
Giczewska A, Pastuszak K, Houweling M, Abdul K, Faaij N, Wedekind L, et al.
Neurooncol Adv . 2023 Dec; 5(1):vdad134. PMID: 38047207
Background: In recent years, drug combinations have become increasingly popular to improve therapeutic outcomes in various diseases, including difficult to cure cancers such as the brain cancer glioblastoma. Assessing the...
6.
Houweling M, Giczewska A, Abdul K, Nieuwenhuis N, Kucukosmanoglu A, Pastuszak K, et al.
Neurooncol Adv . 2023 Jul; 5(1):vdad073. PMID: 37455945
Background: IDH-wildtype glioblastoma (GBM) is a highly malignant primary brain tumor with a median survival of 15 months after standard of care, which highlights the need for improved therapy. Personalized...
7.
Cygert S, Pastuszak K, Gorski F, Sieczczynski M, Juszczyk P, Rutkowski A, et al.
Cancers (Basel) . 2023 May; 15(8). PMID: 37190262
Liquid biopsies offer minimally invasive diagnosis and monitoring of cancer disease. This biosource is often analyzed using sequencing, which generates highly complex data that can be used using machine learning...
8.
Gao Y, Liu C, Li H, Xiong X, Li G, In t Veld S, et al.
Protein Cell . 2023 Mar; 14(6):579-590. PMID: 36905391
Platelets are reprogrammed by cancer via a process called education, which favors cancer development. The transcriptional profile of tumor-educated platelets (TEPs) is skewed and therefore practicable for cancer detection. This...
9.
In t Veld S, Arkani M, Post E, Antunes-Ferreira M, DAmbrosi S, Vessies D, et al.
Cancer Cell . 2022 Sep; 40(9):999-1009.e6. PMID: 36055228
Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for...
10.
Lukasiewicz M, Pastuszak K, Lapinska-Szumczyk S, Rozanski R, In t Veld S, Bienkowski M, et al.
Cancers (Basel) . 2021 Nov; 13(22). PMID: 34830891
Background: Liquid biopsy is a minimally invasive collection of a patient body fluid sample. In oncology, they offer several advantages compared to traditional tissue biopsies. However, the potential of this...